Status
Conditions
Treatments
About
This study will carry out a detailed descriptive analysis of a large population of patients with hereditary retinal dystrophies (HRD): clinical, paraclinical and genetic data.
The information drawn from these analyzes will provide a better understanding of the pathophysiology of these rare diseases and this may ultimately impact the medical management of patients (targeted therapy).
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
Exclusion criteria
- Patient under a measure of legal protection
103 participants in 1 patient group
Loading...
Central trial contact
Amélie YAVCHITZ
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal